Bactiguard Holding Overview
- Year Founded
-
2005

- Status
-
Public
- Employees
-
147

- Stock Symbol
-
BACTI B

- Investments
-
2
- Share Price
-
$3.04
- (As of Thursday Closing)
Bactiguard Holding General Information
Description
Bactiguard Holding AB is a medical device company. It is engaged in the development of infection prevention solutions, which reduce the risk of infections and the use of antibiotics. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. Its portfolio contains urinary catheters, endotracheal tubes, central venous catheters, Hydrocyn for disinfection and wound care, as well as sutures and other wound care products. Its geographical segments are United States, Sweden, Malaysia, China, Thailand, Bangladesh, New Zeeland, and Other countries.
Contact Information
Website
www.bactiguard.comCorporate Office
- Vasagatan 11
- 111 20 Stockholm
- Sweden
Corporate Office
- Vasagatan 11
- 111 20 Stockholm
- Sweden
Bactiguard Holding Stock Performance
As of 19-Jun-2025, Bactiguard Holding’s stock price is $3.04. Its current market cap is $106M with 35M shares.
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$3.04 | $3.01 | $2.21 - $7.31 | $106M | 35M | 6.12K | -$0.07 |
Bactiguard Holding Financials Summary
As of 31-Mar-2025, Bactiguard Holding has a trailing 12-month revenue of $24.1M.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 114,363 | 124,900 | 226,905 | 372,973 |
Revenue | 24,122 | 23,041 | 19,192 | 22,348 |
EBITDA | 2,716 | 2,046 | (8,491) | (49) |
Net Income | (2,313) | (2,819) | (13,019) | (5,212) |
Total Assets | 57,485 | 59,447 | 66,258 | 77,427 |
Total Debt | 17,101 | 20,643 | 23,324 | 22,882 |
Bactiguard Holding Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Bactiguard Holding Comparisons
Industry
Financing
Details
Bactiguard Holding Competitors (13)
One of Bactiguard Holding’s 13 competitors is Endologix, a Corporation company based in Irvine, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Endologix | Corporation | Irvine, CA | ||||
Cordis | Private Equity-Backed | Miami Lakes, FL | ||||
Bausch & Lomb-Iom | Corporation | Vimodrone, Italy | ||||
Terumo | Corporation | Tokyo, Japan | ||||
Alvimedica | Corporation | Istanbul, Turkey |
Bactiguard Holding Patents
Bactiguard Holding Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4281599-A1 | Silver free surface coating | Pending | 12-Apr-2022 | ||
AU-2023253098-A1 | Silver free surface coating | Pending | 12-Apr-2022 | ||
CA-3208238-A1 | Electro-activated super oxidized water and method of synthesizing the same | Pending | 12-Mar-2021 | ||
EP-4304991-A1 | Electro-activated super oxidized water and method of synthesizing the same | Pending | 12-Mar-2021 | ||
US-20240317615-A1 | Electro-activated super oxidized water and method of synthesizing the same | Pending | 12-Mar-2021 | C02F1/4674 |
Bactiguard Holding Signals
Bactiguard Holding Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Bactiguard Holding Investments & Acquisitions (2)
Bactiguard Holding’s most recent deal was a Early Stage VC with Teint for . The deal was made on 18-Apr-2023.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Teint | 18-Apr-2023 | Early Stage VC | Personal Products | ||
Vigilenz Medical Devices | 28-Feb-2020 | Merger/Acquisition | Medical Supplies |
Bactiguard Holding ESG
Risk Overview
Risk Rating
Updated October, 15, 2024
24.13 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,673
Rank
Percentile

Healthcare
Industry
of 564
Rank
Percentile

Medical Supplies
Subindustry
of 58
Rank
Percentile

Bactiguard Holding FAQs
-
When was Bactiguard Holding founded?
Bactiguard Holding was founded in 2005.
-
Where is Bactiguard Holding headquartered?
Bactiguard Holding is headquartered in Stockholm, Sweden.
-
What is the size of Bactiguard Holding?
Bactiguard Holding has 147 total employees.
-
What industry is Bactiguard Holding in?
Bactiguard Holding’s primary industry is Therapeutic Devices.
-
Is Bactiguard Holding a private or public company?
Bactiguard Holding is a Public company.
-
What is Bactiguard Holding’s stock symbol?
The ticker symbol for Bactiguard Holding is BACTI B.
-
What is the current stock price of Bactiguard Holding?
As of 19-Jun-2025 the stock price of Bactiguard Holding is $3.04.
-
What is the current market cap of Bactiguard Holding?
The current market capitalization of Bactiguard Holding is $106M.
-
What is Bactiguard Holding’s current revenue?
The trailing twelve month revenue for Bactiguard Holding is $24.1M.
-
Who are Bactiguard Holding’s competitors?
Endologix, Cordis, Bausch & Lomb-Iom, Terumo, and Alvimedica are some of the 13 competitors of Bactiguard Holding.
-
What is Bactiguard Holding’s annual earnings per share (EPS)?
Bactiguard Holding’s EPS for 12 months was -$0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »